{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:47:29Z","timestamp":1773294449798,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/bf03350817","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T22:35:19Z","timestamp":1397169319000},"page":"776-779","source":"Crossref","is-referenced-by-count":26,"title":["Treatment of severe psychosis due to ectopic Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"30","author":[{"given":"Y. M.","family":"Bilgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. E.","family":"van der Wiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R. A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. W.","family":"De Herder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BF03350817_CR1","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess Es, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997, 82: 912\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-114-2-143","volume":"114","author":"AJ Lely van der","year":"1991","unstructured":"van der Lely AJ, Foeken K, van der Mast RC, Lamberts SW. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Internal Med 1991, 114: 143\u20134.","journal-title":"Ann Internal Med"},{"key":"BF03350817_CR3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-61-3-536","volume":"61","author":"LK Nieman","year":"1985","unstructured":"Nieman LK, Chrousos GP, Kellner C, et al. Succesful treatment of Cushing\u2019s syndrome with glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985, 61: 536\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","volume":"21","author":"JK Belanoff","year":"2001","unstructured":"Belanoff JK, Flores BH, Kalezhan M, Sund B, Shatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopaharmacol 2001, 21: 516\u201321.","journal-title":"J Clin Psychopaharmacol"},{"key":"BF03350817_CR5","first-page":"4104","volume":"86","author":"J Krakoff","year":"2001","unstructured":"Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK. Use of parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing\u2019s syndrome. J Clin Endocrinol Metab 2001, 86: 4104\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR6","first-page":"3542","volume":"83","author":"WM Drake","year":"1998","unstructured":"Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing\u2019s syndrome and peritonitis. J Clin Endocrinol Metab 1998, 83: 3542\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR7","first-page":"3568","volume":"86","author":"JW Chu","year":"2001","unstructured":"Chu JW, Matthias DF, Belanoff J, Shatzberg A, Hoffman AR, Feldman D. Successful long-term treatment of refractory Cushing\u2019s disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab 2001, 86: 3568\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archfami.7.3.219","volume":"7","author":"JR Goldberg","year":"1998","unstructured":"Goldberg JR, Plescia MG, Anastasio GD. Mifepristone (RU 486) current knowledge and future prospects. Arch Fam Med 1998, 7: 219\u201322.","journal-title":"Arch Fam Med"},{"key":"BF03350817_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jcem-63-3-639","volume":"63","author":"X Bertagna","year":"1986","unstructured":"Bertagna X, Bertagna C, Laudat MH, Husson JM, Girard F, Luton JP. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing\u2019s syndrome. J Clin Endocrinol Metab 1986, 63: 639\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR10","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","volume":"70","author":"HM Schulte","year":"1990","unstructured":"Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing\u2019s syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990, 70: 1426\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03350817_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(86)90811-1","volume":"1","author":"R Gartner","year":"1986","unstructured":"Gartner R, Albrecht M, Muller OA. Effect of etomidate on hypercortisolism due to ectopic ACTH production. Lancet 1986, 1: 275.","journal-title":"Lancet"},{"key":"BF03350817_CR12","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab 2005, 90: 4955\u201362.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350817\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:52:19Z","timestamp":1558522339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF03350817"],"URL":"https:\/\/doi.org\/10.1007\/bf03350817","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}